Article info

Original research
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

Authors

  • Shujuan Zhou The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Fanyan Meng The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Shiyao Du The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Hanqing Qian The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Naiqing Ding The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Huizi Sha The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Mei Zhu The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaoxiao Yu The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Lifeng Wang The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Baorui Liu The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  • Jia Wei The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jia Wei; jiawei99{at}nju.edu.cn; Dr Baorui Liu; baoruiliu{at}nju.edu.cn
View Full Text

Citation

Zhou S, Meng F, Du S, et al
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

Publication history

  • Accepted April 2, 2021
  • First published May 13, 2021.
Online issue publication 
May 13, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.